Anders Mellemgaard
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Oncology top 1%
- Cancer Risks and Factors
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 34
- Lung Cancer Diagnosis and Treatment 16
- Renal cell carcinoma treatment 15
- Oncology 37
- Cancer Risks and Factors 9
- Colorectal Cancer Screening and Detection 6
- Lung Cancer Research Studies 6
- Global Cancer Incidence and Screening 5
- Cancer survivorship and care 5
- Co-authors
- Jørgen H. Olsen (11 shared papers)Joachim von Pawel (10 shared papers)Henrik Møller (13 shared papers)Giorgio V. Scagliotti (3 shared papers)Johan Vansteenkiste (2 shared papers)Keunchil Park (2 shared papers)Raghunadharao Digumarti (2 shared papers)Janusz Rolski (2 shared papers)
- Journals
- International Journal of Cancer (12 papers)European Journal of Cancer (8 papers)Annals of Oncology (7 papers)Lung Cancer (6 papers)Acta Oncologica (6 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Anders Mellemgaard
116 papers receiving 8.8k citations
Anders Mellemgaard's Hit Papers
Peers
Comparison fields: 5 of 120
- Pulmonary and Respiratory Medicine 4.7k
- Oncology 2.2k
- Cancer Research 596
- Genetics 509
- Biological Psychiatry 22
Countries citing papers authored by Anders Mellemgaard
This map shows the geographic impact of Anders Mellemgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Mellemgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Mellemgaard more than expected).
Fields of papers citing papers by Anders Mellemgaard
This network shows the impact of papers produced by Anders Mellemgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Mellemgaard. The network helps show where Anders Mellemgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Mellemgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer Hit paper breakdown → | 2008 | 2718 |
| 2 | Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial Hit paper breakdown → | 2014 | 778 |
| 3 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes Hit paper breakdown → | 2017 | 514 |
| 4 | 1994 | 378 | |
| 5 | Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study Hit paper breakdown → | 2020 | 354 |
| 6 | Detection and characterization of lung cancer using cell-free DNA fragmentomes Hit paper breakdown → | 2021 | 335 |
| 7 | 1990 | 219 | |
| 8 | 1995 | 199 | |
| 9 | 1996 | 155 | |
| 10 | 1995 | 150 | |
| 11 | 1995 | 139 | |
| 12 | 2020 | 138 | |
| 13 | 1995 | 117 | |
| 14 | 2013 | 111 | |
| 15 | 2016 | 109 | |
| 16 | 1995 | 99 | |
| 17 | 1996 | 79 | |
| 18 | 2012 | 79 | |
| 19 | 1994 | 78 | |
| 20 | 2013 | 74 |
About Anders Mellemgaard
Anders Mellemgaard is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 117 papers that have together received 9.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Diagnosis and Treatment (16 papers), Renal cell carcinoma treatment (15 papers), Cancer Risks and Factors (9 papers), Colorectal Cancer Screening and Detection (6 papers), Lung Cancer Research Studies (6 papers), Global Cancer Incidence and Screening (5 papers) and Cancer survivorship and care (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Oncology (2.2k citations), Cancer Research (596 citations), Genetics (509 citations) and Biological Psychiatry (22 citations). Anders Mellemgaard has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Jørgen H. Olsen, Joachim von Pawel, Henrik Møller, Giorgio V. Scagliotti, Johan Vansteenkiste, Keunchil Park, Raghunadharao Digumarti, Janusz Rolski, Christian Manegold and Tuncay Göksel. Their work appears in journals such as International Journal of Cancer, European Journal of Cancer, Annals of Oncology, Lung Cancer and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.